Joint Formulary & PAD

Artificial saliva - Dry mouth

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Pastilles
Associated Icons :
SPC
Restrictions / Comments :
 

Status 2

Green (see narrative)
Formulations :
  • Oromucosal gel
Associated Icons :
SPC
Restrictions / Comments :
Important

ASPH and RSFT - only for dry mouth associated with radiotherapy or sicca syndrome (Sjögren's syndrome).

SASH - use Oralieve gel for general dry mouth.

 

Status 3

Green (see narrative)
Formulations :
  • Oromucosal spray
Associated Icons :
SPC
Restrictions / Comments :
Important

Symptomatic treatment of dry mouth.

ASPH restrict to oncology.

SASH use SALIVEZE brand.

 

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Artificial saliva
Indication :
Dry mouth
Group Name :
Keywords :
Sicca syndrome, Sjogren's syndrome, saliva replacement
Brand Names Include :
Biotene Oralbalance, BioXtra, Oralieve, Saliva Orthana, Salivix, Saliveze
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
3

Other Indications

Below are listed other indications that Artificial saliva is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Dry mouth.

Committee Recommendations (2)

17 Jun 25 - SASH DTG

SASH DTG agreed the use of Oralieve gel and Saliveze spray as options for dry mouth.

This drug has been included on the joint formulary having been agreed by the DTC of at least one Surrey Heartlands Acute Trust.

See “Formulary Status” to identify where this drug has been agreed for use.